SNDX SYNDAX PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Public Offering Syndax Pharmaceuticals announced the closing of its recent public offering of common stock and the exercise in full of the underwriters' option to purchase additional shares.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC